DekaBank Deutsche Girozentrale
OSIR

DekaBank Deutsche Girozentrale’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-16,000
Closed -$86K – 1102
2016
Q1 		$86K Sell
16,000
-1,300
-8% -$9.08K ﹤0.01% 981
2015
Q4 		$180K Hold
17,300
– – ﹤0.01% 888
2015
Q3 		$320K Buy
17,300
+600
+4% +$11.6K ﹤0.01% 778
2015
Q2 		$325K Buy
16,700
+600
+4% +$10.6K ﹤0.01% 790
2015
Q1 		$283K Sell
16,100
-2,300
-13% -$38.6K ﹤0.01% 828
2014
Q4 		$284K Sell
18,400
-1,700
-8% -$22.8K ﹤0.01% 803
2014
Q3 		$253K Buy
20,100
+500
+3% +$7.13K ﹤0.01% 778
2014
Q2 		$306K Sell
19,600
-1,300
-6% -$19.1K ﹤0.01% 699
2014
Q1 		$274K Buy
20,900
+2,100
+11% +$32.9K ﹤0.01% 673
2013
Q4 		$313K Buy
18,800
+400
+2% +$6.38K 0.01% 609
2013
Q3 		$306K Buy
+18,400
New +$272K 0.01% 600

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

DekaBank Deutsche Girozentrale's OSIR Position: Q2 2016 in Review

DekaBank Deutsche Girozentrale sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2016, closing a stake of 16,000 shares — an estimated $86K sold.

DekaBank Deutsche Girozentrale first reported a position in OSIR in Q3 2013 and held it in 11 quarters. The position peaked at $325K in Q2 2015. 68 funds tracked by Wall St. Rank hold OSIR as of Q2 2016.

  • DekaBank Deutsche Girozentrale reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 16,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $86K.
  • DekaBank Deutsche Girozentrale first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 11 quarters.
  • DekaBank Deutsche Girozentrale's Osiris Therapeutics, Inc. Common Stock position peaked at $325K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2016.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2016, filed 4 Aug 2016.